OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Allergy Asthma & Immunology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection	168
Update in primary immune deficiencies for the practicing allergist/clinical immunologist	166
Asthma, in quest of optimizing care	154
ATYPICAL MANIFESTATIONS OF DRESS SYNDROME WITHOUT EOSINOPHILIA. CASE REPORT	92
A CASE OF ANAPHYLAXIS TO KETOROLAC IN A PEDIATRIC PATIENT	85
CHARACTERIZING PEDIATRIC NATIVE AMERICAN PATIENTS WITH EOSINOPHILIC GASTROINTESTINAL DISEASE AT A SINGLE TERTIARY CARE CENTER	83
DRUG ALLERGY OR MAST CELL ACTIVATION?	82
ASSESSING OUTCOMES OF A DEDICATED REFERRAL PATHWAY FOR EVALUATION OF PENICILLIN ALLERGY DURING PREGNANCY	80
UNPREDICTABLE AIRWAY COLLAPSE! A CASE OF ACQUIRED ANGIOEDEMA ASSOCIATED WITH B-CELL LYMPHOMA.	68
SAFE ADMINISTRATION OF GCSF AFTER GRADED CHALLENGE IN PATIENT WITH DELAYED CUTANEOUS DRUG HYPERSENSITIVITY REACTION	64
A CASE OF AUTO-INFLAMMATORY DISEASE MIMICKING IMMUNODEFICIENCY	55
A NOVEL CASE OF FPIES AFTER PINE NUT FOOD CHALLENGE IN AN 18-YEAR-OLD FEMALE	53
UNIQUE PRESENTATION OF HYPEREOSINOPHILIC SYNDROME IN THE POSTPARTUM PERIOD WITH ATYPICAL FEATURES AND THERAPEUTIC CHALLENGES	53
Editorial Board	52
AMELIORATION OF SEVERE EXTRAGENITAL WARTS USING HPV VACCINATION: CASE REPORT AND SURVEY OF THE LITERATURE	49
13.2 MG INTRANASAL EPINEPHRINE TREATMENT IN CONGESTION SHOWS INCREASED BIOAVAILABILITY WITHOUT PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATION	49
Disparity between mold immunotherapy dosing and practice parameter recommendations in a large healthcare setting	47
Consideration of pulmonary hypertension in the evaluation of common variable immunodeficiency	47
RARE MUTATION IN AIRE GENE IDENTIFIED IN PATIENT WITH VERY EARLY ONSET IBD	46
POST THYMECTOMY: AN EXAMPLE OF IMMUNE DYSREGULATION?	45
A NOVEL PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT VARIANT IDENTIFIED IN T-B-NK+ SEVERE COMBINED IMMUNODEFICIENCY	42
APPROACHING THE STIFF UPPER LIP: A CASE OF PSEUDOANGIOEDEMA DIAGNOSED AS OROFACIAL GRANULOMATOSIS	41
OMALIZUMAB: A POTENTIAL LONG-TERM THERAPEUTIC ALTERNATIVE FOR REFRACTORY DELAYED PRESSURE URTICARIA?	41
LATE-ONSET COMBINED IMMUNE DEFICIENCY IN A PATIENT WITH ADENOSINE DEAMINASE GENE MUTATION	39
A PATIENT WITH KABUKI SYNDROME AND HYPOGAMMAGLOBULINEMIA DEVELOPS BURKITT LYMPHOMA	38

RECURRENT LUNG INFECTIONS IN A HETEROZYGOUS CARRIER OF NOVEL NSMCE3 MUTATION.	38
A UNIQUE CLINICAL PRESENTATION OF COMMON VARIABLE IMMUNODEFICIENCY: MALAKOPLAKIA OF RECTUM.	37
P061 BENRALIZUMAB IS EFFECTIVE IN REDUCING ASTHMA EXACERBATIONS: RESULTS FROM THE ZEPHYR 2 STUDY	34
P093 IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) 20% SOLUTION ADMINISTRATION IN PRIMARY IMMUNODEFICIENCY DISEASES: A RETROSPECTIVE CHART REVIEW	34
SEVERE INFLAMMATORY RESPONSE SYNDROME AFTER TMP-SMX IN A HEALTHY PATIENT	34
P070 EFFICACY OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA STRATIFIED BY BLOOD EOSINOPHIL COUNT	34
M007 DRESS REACTION TO ANAKINRA IN A PATIENT WITH SEVERE SYSTEMIC JUVENILE ARTHRITIS (SJIA)	33
P196 PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS	33
A022 ON-DEMAND ORAL TREATMENT WITH KVD900 FOR HAE ATTACKS ACHIEVES RAPID EXPOSURE AND IMPROVES PATIENT OUTCOMES	33